A Clinical trial to study the effect of the drug Perungaya Chooranam in patients having Diabetes Mellitus (Madhumegam)
- Conditions
- MALE AND FEMALE WITH POLYURIA,POLYDYPSIA,BURNING SENSATION AND NUMBNESS OVER THE FOOT AND PALM
- Registration Number
- CTRI/2018/03/012505
- Lead Sponsor
- Government Siddha Medical College
- Brief Summary
This is a single Non randomised open clinical trial to study the safety and efficacy of Siddha trial drug Perungaya chooranam. The trial drug is given 2grams twice a day for 90 days. Clinical trial is conducted after conducting Pre clinical toxicity study. The trial drug Perungaya chooranam is mentioned in Sarabenthira vaithiya rathnavali. During the trial all the study related data will be recorded and documented. After the completion of trial all the data will be analysed statistically.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- All
- Target Recruitment
- 40
- Newly identified type II cases only Subject within 30-60 years Blood glucose(F)- 120-140mg/dl Blood glucose(PP)-180-280mg/dl Blood glucose(R)-200-300mg/dl HbA1C.
- 6.5 TO 8% Polyuria Polyphagia Polydypsia Nocturia Fatigue.
H/O Insulin Dependent Diabetes Mellitus H/O Cardiovascular Disease H/O Diabetic Nephropathy H/O Diabetic Retinopathy Pregnant Women, Lactating mothers,T.B affected individuals.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary outcome is mainly assessed by reduced blood sugar and HbA1C Level and reduced in clinical symptoms 90 Days
- Secondary Outcome Measures
Name Time Method Secondary outcome is assessed by comparing the safety parameters before and after treatment 90 DAYS
Trial Locations
- Locations (1)
Aringar Anna Government Hospital of Indian Medicine
🇮🇳Chennai, TAMIL NADU, India
Aringar Anna Government Hospital of Indian Medicine🇮🇳Chennai, TAMIL NADU, IndiaDr Nithya KPrincipal investigator9176808837nithyb4u@gmail.com